Hospital Universitario Vall d'Hebrón - PPDS

Barcelona 0825

0 studies enrolling now · 9 studies all time

What they study most

Advanced Cholangiocarcinoma, Cytomegalovirus (CMV), Dilated Cardiomyopathy, FGFR2 Gene Mutation, Lamin A/C Gene Mutation, MSS, Metastatic or Unresectable Cutaneous Melanoma, Primary Biliary Cholangitis, RAS-mutant Colorectal Cancer, Small Cell Lung Cancer Extensive Stage, Small Cell Lung Cancer Recurrent, Small Cell Lung Carcinoma

Studies at this site

• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors — Completed
• A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation — Stopped early
• KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer — Stopped early
• A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants — Completed
• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed
• Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation — Completed
• Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed